Literature DB >> 30681739

Using only a subset of pneumococcal serotypes is reliable for the diagnosis of specific antibody deficiency in children: A proof-of-concept study.

Maleewan Kitcharoensakkul1,2, Andrew L Kau3, Leonard B Bacharier1, Charles W Goss4, Avraham Beigelman1.   

Abstract

Entities:  

Keywords:  pneumococcal titers; specific antibody deficiency

Mesh：

Substances：

Year:  2019        PMID： 30681739      PMCID： PMC6488433          DOI： 10.1111/pai.13026

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN： 0905-6157            Impact factor:   6.377


× No keyword cloud information.
  10 in total

Review 1.  The immunogenicity of pneumococcal polysaccharides in infants and children: a meta-regression.

Authors:  Craig Laferriere
Journal:  Vaccine       Date:  2011-08-02       Impact factor: 3.641

2.  Clinical and Serologic Response to the 23-valent Polysaccharide Pneumococcal Vaccine in Children and Teens with Recurrent Upper Respiratory Tract Infections and Selective Antibody Deficiency.

Authors:  Jaime Estrada; Maria Najera; Natalie Pounds; Gabriel Catano; Anthony J Infante
Journal:  Pediatr Infect Dis J       Date:  2016-02       Impact factor: 2.129

3.  Assignment of Opsonic Values to Pneumococcal Reference Serum 007sp for Use in Opsonophagocytic Assays for 13 Serotypes.

Authors:  R L Burton; J Antonello; D Cooper; D Goldblatt; K H Kim; B D Plikaytis; L Roalfe; D Wauters; F Williams; G L Xie; M H Nahm; M Akkoyunlu
Journal:  Clin Vaccine Immunol       Date:  2017-02-06

4.  Practice parameter for the diagnosis and management of primary immunodeficiency.

Authors:  Francisco A Bonilla; David A Khan; Zuhair K Ballas; Javier Chinen; Michael M Frank; Joyce T Hsu; Michael Keller; Lisa J Kobrynski; Hirsh D Komarow; Bruce Mazer; Robert P Nelson; Jordan S Orange; John M Routes; William T Shearer; Ricardo U Sorensen; James W Verbsky; David I Bernstein; Joann Blessing-Moore; David Lang; Richard A Nicklas; John Oppenheimer; Jay M Portnoy; Christopher R Randolph; Diane Schuller; Sheldon L Spector; Stephen Tilles; Dana Wallace
Journal:  J Allergy Clin Immunol       Date:  2015-09-12       Impact factor: 10.793

5.  Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology.

Authors:  Jordan S Orange; Mark Ballow; E Richard Stiehm; Zuhair K Ballas; Javier Chinen; Maite De La Morena; Dinakantha Kumararatne; Terry O Harville; Paul Hesterberg; Majed Koleilat; Sean McGhee; Elena E Perez; Jason Raasch; Rebecca Scherzer; Harry Schroeder; Christine Seroogy; Aarnoud Huissoon; Ricardo U Sorensen; Rohit Katial
Journal:  J Allergy Clin Immunol       Date:  2012-09       Impact factor: 10.793

6.  The clinical syndrome of specific antibody deficiency in children.

Authors:  R J Boyle; C Le; A Balloch; M L-K Tang
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

7.  A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides.

Authors:  Jerry W Pickering; Thomas B Martins; Ryan W Greer; M Carl Schroder; Mark E Astill; Christine M Litwin; Stephen W Hildreth; Harry R Hill
Journal:  Am J Clin Pathol       Date:  2002-04       Impact factor: 2.493

8.  Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections.

Authors:  L A Sanders; G T Rijkers; W Kuis; A J Tenbergen-Meekes; B R de Graeff-Meeder; I Hiemstra; B J Zegers
Journal:  J Allergy Clin Immunol       Date:  1993-01       Impact factor: 10.793

9.  Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.

Authors:  H Hidalgo; C Moore; L E Leiva; R U Sorensen
Journal:  Ann Allergy Asthma Immunol       Date:  1996-04       Impact factor: 6.347

Review 10.  Specific Antibody Deficiency: Controversies in Diagnosis and Management.

Authors:  Elena Perez; Francisco A Bonilla; Jordan S Orange; Mark Ballow
Journal:  Front Immunol       Date:  2017-05-22       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.